Core Laboratories Inc (CLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2007 | 12-2006 | 09-2006 | 06-2006 | 03-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 28,989 | 54,223 | 12,456 | 12,149 | 16,030 |
| Receivables | 122,838 | 112,055 | 111,062 | 106,518 | 108,880 |
| Inventories | 32,482 | 30,199 | 31,772 | 31,262 | 27,326 |
| TOTAL | $213,047 | $225,552 | $169,556 | $164,629 | $167,013 |
| Non-Current Assets | |||||
| PPE Net | 86,603 | 87,734 | 87,482 | 83,036 | 81,434 |
| Intangibles | 139,173 | 139,220 | 139,184 | 139,209 | 139,278 |
| Other Non-Current Assets | 49,387 | 48,709 | 24,648 | 24,189 | 18,929 |
| TOTAL | $275,163 | $275,663 | $251,314 | $246,434 | $239,641 |
| Total Assets | $488,210 | $501,215 | $420,870 | $411,063 | $406,654 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,779 | 2,762 | 181 | 777 | 1,660 |
| Accounts payable and accrued liabilities | 33,514 | 37,460 | 30,769 | 33,699 | 30,150 |
| Accrued Expenses | 21,384 | 24,707 | 25,401 | 22,126 | 19,786 |
| TOTAL | $83,383 | $88,920 | $86,511 | $81,005 | $73,657 |
| Non-Current Liabilities | |||||
| Long Term Debt | 300,002 | 300,002 | 107,002 | 103,003 | 91,103 |
| Deferred Revenues | 8,996 | 6,853 | 5,567 | 5,896 | 7,370 |
| Other Non-Current Liabilities | 48,999 | 40,457 | 36,922 | 34,960 | 34,058 |
| TOTAL | $349,001 | $340,459 | $143,924 | $137,963 | $125,161 |
| Total Liabilities | $432,384 | $429,379 | $230,435 | $218,968 | $198,818 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 47,818 | 46,264 | 50,179 | 50,629 | 50,700 |
| Common Shares | 1,525 | 1,450 | 1,446 | 1,441 | 478 |
| Retained earnings | 246,031 | 224,110 | 198,937 | 176,553 | 157,593 |
| Other shareholders' equity | -2,512 | -1,906 | -197 | -366 | 155 |
| TOTAL | $55,826 | $71,836 | $190,435 | $192,095 | $207,836 |
| Total Liabilities And Equity | $488,210 | $501,215 | $420,870 | $411,063 | $406,654 |